Origin Therapeutics Holdings (XCNQ:ORIG) Scaled Net Operating Assets : 0.00 (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Origin Therapeutics Holdings's operating assets for the quarter that ended in Jun. 2023 was C$0.13 Mil. Origin Therapeutics Holdings's operating liabilities for the quarter that ended in Jun. 2023 was C$0.11 Mil. Origin Therapeutics Holdings's Total Assets for the quarter that ended in Mar. 2023 was C$3.37 Mil. Therefore, Origin Therapeutics Holdings's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2023 was 0.00.

Origin Therapeutics Holdings Scaled Net Operating Assets Historical Data

The historical data trend for Origin Therapeutics Holdings's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Scaled Net Operating Assets Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Scaled Net Operating Assets

0.03

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Scaled Net Operating Assets	Get a 7-Day Free Trial				0.02	0.03	0.04	-0.03	0.01

Competitive Comparison of Origin Therapeutics Holdings's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Origin Therapeutics Holdings's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Origin Therapeutics Holdings's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Origin Therapeutics Holdings's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Origin Therapeutics Holdings's Scaled Net Operating Assets falls into.

Origin Therapeutics Holdings Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Origin Therapeutics Holdings's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Sep. 2022 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Sep. 2022 )
=	(Operating Assets (A: Sep. 2022 )	-	Operating Liabilities (A: Sep. 2022 ))	/	Total Assets (A: Sep. 2021 )
=	(0.359	-	0.159)	/	7.059
=	0.03

where

	Operating Assets		(A: Sep. 2022 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	5.588	-	5.229
=	0.359

	Operating Liabilities		(A: Sep. 2022 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	0.159	-	0	-	0
=	0.159

Origin Therapeutics Holdings's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2023 )
=	(Operating Assets (Q: Jun. 2023 )	-	Operating Liabilities (Q: Jun. 2023 ))	/	Total Assets (Q: Mar. 2023 )
=	(0.126	-	0.11)	/	3.369
=	0.00

where

	Operating Assets		(Q: Jun. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	3.191	-	3.065
=	0.126

	Operating Liabilities		(Q: Jun. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	0.11	-	0	-	0
=	0.11

Origin Therapeutics Holdings Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.